Dr. Laleh Safinia
Dr. Laleh Safinia, Commercial Lead, Inflammatory Bowel Disease (IBD) at Janssen EMEA
HSJ PartnersCollaborate for change: Improve IBD patient care in a post covid-19 era
The scale of the covid-19 pandemic demanded greater collaboration between the pharmaceutical industry and the NHS. Both rose to the call and now must work together to address the ongoing impact on wider NHS services.